Correlations of chromosome 17 number with Her2/neu gene copy number by FISH and protein expression by IHC in breast invasive ductal carcinoma

被引：0
作者：
Zhang, S. [1 ]
Shah, S. S. [1 ]
机构：
[1] SUNY Upstate Med Univ, Syracuse, NY USA
来源：
MODERN PATHOLOGY | 2007年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
234
引用
收藏
页码：56A / 56A
页数：1
相关论文
共 50 条
[31]   HER2/neu expression correlates with vasculogenic mimicry in invasive breast carcinoma [J].
Liu, Tieju ;
Sun, Baocun ;
Zhao, Xiulan ;
Gu, Qiang ;
Dong, Xueyi ;
Yao, Zhi ;
Zhao, Nan ;
Chi, Jiadong ;
Liu, Ning ;
Sun, Ran ;
Ma, Yuemei .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2013, 17 (01) :116-122
[32]   The role of HER2/neu overexpression/amplification in the progression of ductal carcinoma in situ to invasive carcinoma of the breast [J].
Latta, EK ;
Tjan, S ;
Parkes, RK ;
O'Malley, FP .
MODERN PATHOLOGY, 2002, 15 (12) :1318-1325
[33]   HER2/neu gene amplification and copy numbers of HER2/neu and chromosome 17 assessed by fluorescence in situ hybridization (FISH) are not predictive of outcome in resected pancreatic cancer. [J].
Krasinskas, AM ;
Sharif, S ;
Cieply, K ;
Potter, D ;
Elinoff, B ;
Liao, L ;
Ramanathan, RK .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) :337S-337S
[34]   Association of HER2/neu gene amplification and copy numbers of HER2/neu and chromosome 17 with tumor characteristics in resected colorectal cancer (CRC). [J].
Sharif, S ;
Ramanathan, R ;
Cieply, K ;
Sasatomi, E ;
Elinoff, B ;
Liao, L ;
Krasinskas, AM .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) :269S-269S
[35]   Incidence and Significance of Fluorescent In Situ Hybridization (FISH) HER2 Gene Amplification by HER2 Gene Copy Number of ≥ 6.0 with Her2/CEP17 Ratio of <2.0 in Breast Cancer [J].
Apple, Sophia .
LABORATORY INVESTIGATION, 2017, 97 :29A-30A
[36]   Incidence and Significance of Fluorescent In Situ Hybridization (FISH) HER2 Gene Amplification by HER2 Gene Copy Number of ≥6.0 with Her2/CEP17 Ratio of <2.0 in Breast Cancer [J].
Apple, Sophia .
MODERN PATHOLOGY, 2017, 30 :29A-30A
[37]   Clinical role of HER2 gene amplification and chromosome 17: a study on 154 IHC-equivocal cases of invasive breast carcinoma patients [J].
Afzal, Muhammad ;
Amir, Mohammed ;
Hassan, Muhammad Jawad ;
Hussain, Muhammad Sikander ;
Aziz, Muhammad Naveed ;
Murad, Sheeba ;
Murtaza, Iram ;
Anees, Mariam ;
Sultan, Aneesa .
TUMOR BIOLOGY, 2016, 37 (07) :8665-8672
[38]   Comparison of Breast Tumors with Increased HER2 Copy Number With and Without Polysomy 17 [J].
Field, L. A. ;
Deyarmin, B. ;
Ellsworth, R. E. ;
Shriver, C. D. .
ANNALS OF SURGICAL ONCOLOGY, 2013, 20 :S70-S70
[39]   Prevalence of polysomy 17 by OncoScan in Fluorescence In Situ Hybridization (FISH) HER2 Gene amplification by HER2 gene copy number of > 6.0 with HER2/CEP17 ratio of < 2.0 in breast cancer [J].
Apple, Sophia ;
Murata-Collins, Joyce .
MODERN PATHOLOGY, 2018, 31 :45-45
[40]   Prevalence of polysomy 17 by OncoScan in Fluorescence In Situ Hybridization (FISH) HER2 Gene amplification by HER2 gene copy number of > 6.0 with HER2/CEP17 ratio of < 2.0 in breast cancer [J].
Apple, Sophia ;
Murata-Collins, Joyce .
LABORATORY INVESTIGATION, 2018, 98 :45-45
12345